You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oral immunomodulator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

Necrotizing Enterocolitis Trial in San Fernando (Melatonin 6 MG, Breast Milk)

Recruiting
  • Necrotizing Enterocolitis
  • Melatonin 6 MG
  • Breast Milk
  • San Fernando, LA Union, Philippines
    Ilocos Training and Regional Medical Center
Dec 1, 2021

Immune Thrombocytopenia Trial (VIT D)

Not yet recruiting
  • Immune Thrombocytopenia
  • VIT D
  • (no location specified)
Oct 5, 2023

COVID-19 Vaccine Response in Chronic Respiratory Conditions

Recruiting
  • SARS-CoV Infection
  • COVID-19 vaccine
  • Denver, Colorado
    National Jewish Health
Apr 4, 2022

Ulcerative Colitis Trial (MitoQ, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • MitoQ
  • Placebo
  • (no location specified)
Sep 13, 2022

Oral Ulcer Trial in Beijing (Lenalidomide 10 mg)

Not yet recruiting
  • Oral Ulcer
  • Lenalidomide 10 mg
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 5, 2022

Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

Withdrawn
  • Hodgkin Lymphoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 28, 2022

Crohn Disease Trial in Canada, United States (Vedolizumab, Adalimumab, Methotrexate)

Completed
Has Results
  • Crohn Disease
  • Dothan, Alabama
  • +31 more
Jul 11, 2022

Multiple Myeloma Trial in Beijing (Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone)

Recruiting
  • Multiple Myeloma
  • Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
  • Beijing, Beijing, China
    PekingUMCH
Aug 15, 2021

Relapsing Remitting Multiple Sclerosis Trial in Worldwide (Pleneva TM BGC20-0134, Placebo)

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • Pleneva TM BGC20-0134
  • Placebo
  • Gent, Belgium
  • +34 more
Jun 2, 2022

Mental Disorder Trial in France (immunomodulatory treatment by rituximab)

Not yet recruiting
  • Mental Disorder
  • immunomodulatory treatment by rituximab
  • Bordeaux, France
  • +8 more
Jul 7, 2023

Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia Trial (Nigella Sativa Oil capsule)

Not yet recruiting
  • Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia
  • Nigella Sativa Oil capsule
  • (no location specified)
Jul 11, 2023

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Eosinophilic Asthma Trial in Taipei (AD17002, Placebo)

Not yet recruiting
  • Eosinophilic Asthma
  • Taipei, Taiwan
    Taipei Medical University Hospital
Aug 16, 2023

Ulcerative Colitis Trial in Spain (Methylprednisolone, Prednisone)

Active, not recruiting
  • Ulcerative Colitis
  • Santiago de Compostela, A Coruña, Spain
  • +28 more
Jan 26, 2022

First Manifestation of Steroid Sensitive Nephrotic Syndrome Trial in Paris (Levamisole Hydrochloride, Placebo)

Completed
  • First Manifestation of Steroid Sensitive Nephrotic Syndrome
  • Levamisole Hydrochloride
  • Placebo
  • Paris, France
    Hôpital Robert Debré
Jun 7, 2022

Microparticle Delivered STING Agonist in Control of Experimental

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Blood Draw
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 20, 2023

Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
Nov 22, 2021

Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

Terminated
  • Hepatitis B, Chronic
  • Granulocyte Macrophage-colony Stimulating Factor
  • Entecavir
  • Beijing, Beijing, China
    302 Military Hospital
Mar 9, 2022

Vitiligo, Vitiligo, Generalized, Autoimmune Trial in Monterrey (Oral Vitamin D, NB-UVB Phototherapy, Placebo)

Active, not recruiting
  • Vitiligo
  • +4 more
  • Oral Vitamin D
  • +2 more
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Mar 14, 2022

COVID-19 Trial in United States (Niclosamide, Placebo)

Recruiting
  • COVID-19
  • Sheffield, Alabama
  • +8 more
Apr 22, 2022

Crohn Disease, Child, Only, Biologic; Inadequate Trial (Infliximab)

Not yet recruiting
  • Crohn Disease
  • +2 more
  • (no location specified)
Sep 20, 2022

Ulcerative Colitis, Crohn Disease Trial in United States (Pragmatic)

Recruiting
  • Ulcerative Colitis
  • Crohn Disease
  • Pragmatic
  • Irvine, California
  • +20 more
Jan 9, 2023

Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer Trial in Milano

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • +3 more
  • Milano, MI, Italy
    Istituto Nazionale dei Tumori
Jan 24, 2022